Our goal is to provide more deuterated synthetic routes to meet the demand for various types of product portfolios, and to continuously expand our presence in this important market for deuterated drugs.
BOC Sciences, a U.S.-based chemical technology company, is launching an integrated deuterium chemically labeled DCL™ platform to help customers develop innovative deuterated chemical entities. Our platform enables efficient and low-cost drug development pipelines, and has very broad potential in multiple therapeutic areas. Our DCL™ technology will drive the emergence of new therapeutics.
BOC Sciences firmly pursues our mission. We guarantee the quality and standard of the technology platform we provide, which is our most important commitment to our customers.
We're trying to be an integral part of a new world where deuterium chemistry-based therapy is a routine, accessible way to help people get better.
BOC Sciences prides itself on providing unique deuterated technology solutions for the chemical pharmaceutical industries
95% of employees of BOC Sciences have master's degrees or above. We excel at innovating based on the latest breakthrough scientific advances.
BOC Sciences is always on call and our goal is to provide our customers with excellent technical support to help them develop their target molecules.